Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1

Conditions

Panic Disorder 1Neoplasms 1Lung Neoplasms 1Anxiety Disorders 1

Interventions

Cyclophosphamide 909Carboplatin 787pembrolizumab 744Paclitaxel 742Cisplatin 709Bevacizumab 706Gemcitabine 619Docetaxel 579Rituximab 548Radiotherapy 541Dexamethasone 511Nivolumab 488Doxorubicin 444Fluorouracil 392Capecitabine 376Etoposide 358Pemetrexed 337Cytarabine 335Oxaliplatin 333Lenalidomide 328Prednisone 326fludarabine phosphate 316Erlotinib Hydrochloride 314Trastuzumab 300Leucovorin 299fludarabine 296Vincristine 287Filgrastim 284Bortezomib 284Cetuximab 276

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Has results × Relaxation Therapy × Clear all
NCT04229381 2023-11-15

ROAR-LCT

Ohio State University Comprehensive Cancer Center

Phase NA Completed
18 enrolled 9 charts
Thoracic

Lung Neoplasms

NCT00735618 2011-12-19

Relaxation and Heart Rate Variability

M.D. Anderson Cancer Center

Phase NA Completed
20 enrolled 3 charts

Anxiety Disorders, Neoplasms, Panic Disorder

Data powered by HemOnc (CC BY 4.0) Colophon âš¡